Savara SVRA
NASDAQ SVRA
$5.38 +0.01 (+0.09%)
As of: Sep 4, 2026 · 3:20 PM EDT

Savara (SVRA) Change in Cash (2010 - 2026)

Savara (SVRA) posted quarterly Change in Cash of $5.6 million for Q1 2026, up 26.72% year-over-year from $4.4 million in Q1 2025, and down 66.8% quarter-over-quarter from $16.9 million in Q4 2025.

Analysis

Savara (SVRA) Change in Cash (2010 - 2026) Analysis & Trends

Savara (SVRA) has reported Change in Cash for 17 consecutive years, with $5.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Cash rose 26.72% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $19.2 million (up 594.15% YoY), while the FY2025 annual figure was $18.1 million, up 257.56% from the prior year.
  • Change in Cash slipped to $5.6 million in Q1 2026 per SVRA's latest filing, from $16.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $45.2 million in Q1 2022 and bottomed at -$67.7 million in Q4 2022.
  • Historically, Change in Cash has averaged $281117.6 across 5 years, with a median of -$1.1 million in 2023.
  • On a YoY basis, Change in Cash climbed as much as 510.18% in 2022 and fell as far as 533.86% in 2022.
  • Savara's Change in Cash stood at -$67.7 million in 2022, then jumped by 98.37% to -$1.1 million in 2023, then tumbled by 470.05% to -$6.3 million in 2024, then surged by 368.34% to $16.9 million in 2025, then slumped by 66.8% to $5.6 million in 2026.
  • Business Quant data shows SVRA's Change in Cash at $5.6 million in Q1 2026, $16.9 million in Q4 2025, and -$1.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 374.50 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 225.59 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -37.42 Mn
10 Savara 1.36 Bn 1.36 Bn - 3.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.01 Mn
Mar 31, 2026 5.61 Mn
Dec 31, 2025 16.90 Mn
Sep 30, 2025 -1.16 Mn
Jun 30, 2025 -2.12 Mn
Mar 31, 2025 4.43 Mn
Dec 31, 2024 -6.30 Mn
Sep 30, 2024 -2.44 Mn
Jun 30, 2024 7.08 Mn
Mar 31, 2024 -9.80 Mn
Dec 31, 2023 -1.11 Mn
Sep 30, 2023 4.95 Mn
Jun 30, 2023 -11.24 Mn
Mar 31, 2023 -18.12 Mn
Dec 31, 2022 -67.74 Mn
Sep 30, 2022 24.69 Mn
Jun 30, 2022 15.93 Mn
Mar 31, 2022 45.22 Mn
Dec 31, 2021 -10.69 Mn
Sep 30, 2021 4.05 Mn